Bright Minds Biosciences INC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
20-F: Bright Minds Biosciences Inks Independent Contractor Agreement with Torleif Science ApS for CSO Role
Bright Minds Biosciences enters into an independent contractor agreement with Torleif Science ApS, appointing Jan Torleif Pedersen as Chief Science Officer, effective September 22, 2022.